Oryzon Genomics S.A. (BME:ORY)
Spain · Delayed Price · Currency is EUR 2.810
-0.050 (-1.75%)
At close: Mar 18, 2026
Oryzon Genomics Market Cap
Oryzon Genomics has a market cap or net worth of €217.81 million as of March 18, 2026. Its market cap has increased by 16.20% in one year.
Market Cap
217.81M
Enterprise Value
207.20M
Revenue
10.93M
Ranking
n/a
PE Ratio
n/a
Stock Price
€2.81
Market Cap Chart
Since December 14, 2015, Oryzon Genomics's market cap has increased from 122.00M to 217.81M, an increase of 78.53%. That is a compound annual growth rate of 5.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 17, 2026 | 221.69M | -9.60% |
| Dec 31, 2025 | 245.23M | 170.69% |
| Dec 31, 2024 | 90.60M | -16.71% |
| Dec 29, 2023 | 108.78M | -18.27% |
| Dec 30, 2022 | 133.08M | -6.58% |
| Dec 30, 2021 | 142.46M | -32.20% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Grifols | 5.66B |
| Laboratorios Farmaceuticos Rovi | 4.08B |
| Almirall | 2.47B |
| Pharma Mar | 1.44B |
| Clínica Baviera | 804.13M |
| Atrys Health | 223.07M |
| Prim, S.A. | 211.85M |
| Laboratorio Reig Jofre | 192.13M |